Managing Corneal Cystine Crystals in Cystinosis

For patients with ocular symptoms of cystinosis, early intervention, monitoring and management is critical.

Cystinosis Overview
Young girl during an eye exam
Not an actual patient

Early Diagnosis is Crucial

Ocular symptoms of cystinosis may manifest in infancy, and may lead to irreversible damage over time. As part of an integrated treatment plan, continuous symptom monitoring and management are vital in helping prevent vision complications as patients mature.

The following information provides details on this rare disease, as well as clinical approaches to managing the ocular symptoms of cystinosis.

A rare, complex condition

Cystinosis affects multiple organs and systems, with cystine continuously accumulating in lysosomes, eventually forming crystals in cells throughout the body of affected patients.1 Generally diagnosed early in life, patients typically present with severe kidney manifestations.1,2 The kidneys and eyes are the most affected organs.1

Ocular Symptoms

Lysosomal storage disease resulting in cystine accumulation in multiple organs1

Cystinosis is caused by mutations in the CTNS gene that encodes for a cystine transporter3,4:

Designed image of DNA strand
  • CTNS mutations result in absent or defective cystinosin, a lysosomal cystine transporter4,5
  • Impaired transportation results in accumulation of cystine in lysosomes1,3
  • This cystine accumulation leads to cystine crystal formation within lysosomes
in multiple organs and tissues1,3
Designed image of DNA strand Identifying Cystinosis

Cystine accumulation leads to significant health complications, tissue damage, and progressive organ dysfunction1,6

Over time, cystine crystals accumulate in cells throughout the body, eventually leading to symptoms in multiple organs:1,6,7

  • Eyes and the kidneys are the organs most affected1
  • Crystals may affect all parts of the eye8-10, including:
    • Cornea
    • Conjunctiva
    • Iris
    • Retina, which includes the macula and optic nerve
Photograph of three doctors, one holding stethoscope

A well-aligned treatment plan

Cystinosis patients require a multidisciplinary approach to treatment. Bringing together a number of specialists to address and treat symptoms is essential for:

  • Delivering high-quality clinical care
  • Optimizing the patient experience for better medication adherence
  • Mitigating complications, including vision loss

Coordination of Care

REFERENCES: 1. Cystinosis. National Organization for Rare Disorders. https://rarediseases.org/rare-diseases/cystinosis/?filter=ovr-ds-resources. Updated August 1, 2022. Accessed February 8, 2023. 2. Elmonem MA et al. Orphanet J Rare Dis. 2016;11:47. doi:10.1186/s13023-016-0426-y. 3. Wilmer MJ et al. Pediatr Nephrol. 2011;26(2):205-215. 4. Besouw MTP, Levtchenko EN. Improving the prognosis of nephropathic cystinosis. Int J Nephrol Renovasc Dis. 2014;7:297-302. 5. Nesterova N, Gahl WA. Pediatr Nephrol. 2013;28(1):51-59. 6. Gahl WA et al. N Engl J Med. 2002;347(2):111-121. 7. Bäumner S, Weber LT. Front Pediatr. 2018;6:58. doi:10.3389/fped.2018.00058. 8. Liang H et al. Br J Ophthalmol. 2021;105(5):608-613. 9. Tsilou E et al. Surv Ophthalmol. 2007;52(1):97-105. 10. Bayram-Suverza M et al. Indian J Ophthalmol. 2022;70(7):2636-2638.